验证HPV疫苗接种对HPV感染率、宫颈病变及宫颈癌预测影响的系统综述:基于人群水平数据与模型研究
该系统综述检索2005年至2023年6月高收入国家研究,比较模型预测与观察数据中HPV疫苗接种对HPV感染率、宫颈病变及宫颈癌的影响。共纳入1篇系统综述、14项观察性研究和32项模型研究,发现疫苗接种覆盖率与HPV相关结局的相对风险降低存在明确关系,约67%的模型预测对HPV感染率下降比观察性研究荟萃回归的95%CI更乐观,而CIN2+病变的模型预测有48%落在95%CI内。
要点
- 疫苗接种覆盖率与HPV相关结局的相对风险降低存在明确关系。
- 28个数据点中23个显示HPV感染率显著下降,20个数据点中19个显示CIN2+患病率显著下降。
- 约67%的模型预测对HPV感染率下降比观察性研究荟萃回归95%CI更乐观,CIN2+模型预测48%落在95%CI内。
核心结论
- 模型预测与观察数据一致认为HPV疫苗接种可在人群水平对HPV相关结局产生实质性影响。
- 尽管观察数据和模型研究存在较大异质性,但模型预测对CIN2+病变的影响与观察性研究一致,尤其令人鼓舞。
研究设计与样本
- 系统综述,检索Cochrane Library、EMBASE、MEDLINE、Web of Science,纳入2005年至2023年6月2日发表的高收入国家研究。
- 共纳入1篇系统综述、14项观察性研究和32项模型研究,从观察性和模型研究中收集比较疫苗接种前后HPV相关结局的相对风险(RR)。
- 采用荟萃回归确定疫苗接种覆盖率与观察到的相对降低之间的关系,并比较模型预测与观察数据。
主要发现
- 疫苗接种前后HPV疾病相关结局的RR与疫苗接种覆盖率之间存在明确关系。
- 28个数据点中23个显示HPV感染率显著下降,20个数据点中19个显示CIN2+患病率显著下降。
- 约67%(n/N=12/18)的模型预测对HPV感染率下降比观察性研究荟萃回归的95%CI更乐观。
- 对于CIN2+病变,48%(n/N=31/64)的模型预测落在95%CI内。
局限性
- 观察数据和模型研究存在较大异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We compared model predictions with independently published primary data from population-based studies on the impact of HPV vaccination on HPV prevalence, cervical cancer and its precursors. METHODS: We searched Cochrane Library, EMBASE, MEDLINE, Web of Science for studies concerning high-income countries published between 2005 to June 2, 2023. Relative risk (RR) for HPV-related outcomes comparing the pre-vaccination and post-vaccination periods were collected from observational and modelling studies. The relationship between vaccination coverage and observed relative reductions was determined using meta-regressions, and we compared model prediction to observations. FINDINGS: We identified a total of 5649 potential articles, of which one systematic review, 14 observational studies and 32 modelling studies met our inclusion criteria. A clear relation was found between the RR of HPV diseases related outcomes in the pre- versus post-vaccination era and the vaccination coverage, with 23 out of 28 data points and 19 out of 20 data points showing significant reductions in HPV prevalence and CIN2+ prevalence respectively. Around 67 % (n/N = 12/18) of model predictions were more optimistic on HPV prevalence reductions compared to the 95 % CI of the meta-regression derived from observational studies. For CIN2+ lesions, 48 % (n/N = 31/64) of model predictions for CIN2+ outcomes fell within the 95 % CI. INTERPRETATION: Model predictions and observational data agree that HPV vaccination can have a substantial impact on HPV related outcomes on a population level. Despite large heterogeneity in observational data and modelling studies, it is particularly encouraging that model predictions on the impact of HPV vaccination on CIN2+ model lesions align with observational studies. FUNDING: Ontario Health (formerly known as Cancer Care Ontario).
引用
- de Bondt D, Naslazi E, Jansen E, et al. Validating the predicted impact of HPV vaccination on HPV prevalence, cervical lesions, and cervical cancer: A systematic review of population level data and modelling studies. Gynecol Oncol. 2025. PMID: 40101607. doi:10.1016/j.ygyno.2025.03.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。